Lanka Hospital Corporation (LHC) plans to set up one large diagnostic laboratory with four other regional labs with India's Super Religare Labs, a subsidiary of Fortis Healthcare in which LHC plans investing Rs 831 million over the next two years, according to LHC officials.
“First we’ll set up the lab in Colombo and expand to the regions and Fortis Healthcare, the second largest shareholder of Lanka Hospitals and through its subsidiary will partner in consultancy services,” an official said.
Lanka Hospitals hasn’t decided on the name, the official added, saying that it will float a fully owned unit to operate the labs.
Fortis has 28.6% in LHC which they purchased for Rs 3.98 billion from Distilleries Corporation of Sri Lanka (DCSL). The Business Times in January last year reported that LHC is in discussions with many parties and also investors for the possibility of partnerships, joint ventures to set up hospitals within the country.
“Fortis is discussing with LHCL to set up more hospitals in the country and Hambantota and Jaffna are on the cards,” the official added.